{
    "clinical_study": {
        "@rank": "141058", 
        "arm_group": [
            {
                "arm_group_label": "Glucagon", 
                "arm_group_type": "Experimental", 
                "description": "The first recording is a transvaginal ultrasound in midsagittale position for the measurement of the basic uterine contractility 2 minutes before the injection of Glucagon.\nThe second recording is doing the same way 10 minutes after the Glucagon injection, just before the embryo transfer."
            }, 
            {
                "arm_group_label": "Sodium chloride 0.9%", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The first recording is a transvaginal ultrasound in midsagittale position for the measurement of the basic uterine contractility 2 minutes before the injection of the placebo.\nThe second recording is doing the same way 10 minutes after the placebo injection, just before the embryo transfer."
            }
        ], 
        "brief_summary": {
            "textblock": "The success of in vitro fertilization is based mainly on uterine implantation embryo. An\n      excessive uterine contractility may interfere with implantation by a movement of the embryo\n      in the uterus. The inhibition of the uterine contractility may have a positive effect on\n      success rate of in vitro fertilization. It is through parenteral injection of glucagon and\n      its spasmolytic effect on various smooth muscles and thereby on the uterine muscle, at the\n      time of embryo transfer, the investigators intend to improve the pregnancy rates obtained\n      after IVF."
        }, 
        "brief_title": "Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Women With Fertility Disorder", 
        "detailed_description": {
            "textblock": "Women will have a cycle of in vitro fertilization (IVF) and follow the standard protocol\n      established by the clinic ovo or the fertility clinic of CHUM. On the day of embryo\n      transfer, the investigators will administer 1 mg of Glucagon or placebo intramuscularly 10\n      minutes before the embryo transfer. The uterine contractility will be measured by ultrasound\n      before and after injection to document the impact of Glucagon on it and we will proceed to\n      embryo transfer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women doing fertility treatment at the clinic ovo or fertility clinic of CHUM\n\n          -  Less than 40 years old\n\n          -  Women with stimulate in vitro fertilization cycle\n\n          -  Women able to give her consent\n\n        Exclusion Criteria:\n\n          -  Body mass index > 35 kg/m2\n\n          -  Women with diabetes\n\n          -  Women with hypertensive disorders\n\n          -  Women with a blood pressure greater or equal to 140/90 mmHg at the randomization\n             visit\n\n          -  Cons-indication to taking Glucagon:\n\n               -  Hypersensitivity to product\n\n               -  Pheochromocytoma or history of pheochromocytoma\n\n               -  Insulinoma\n\n               -  Taking a beta-blocker (drug interactions)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01674283", 
            "org_study_id": "OVO-12-08"
        }, 
        "intervention": [
            {
                "arm_group_label": "Glucagon", 
                "intervention_name": "Glucagon", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sodium chloride 0.9%", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Glucagon", 
                "Glucagon-Like Peptide 1"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "contact": {
                "last_name": "Shirley Brugerie, Director"
            }, 
            "contact_backup": {
                "email": "s.leblanc@cliniqueovo.com", 
                "last_name": "K\u00e9celle Viaud, RN", 
                "phone": "514-798-2000", 
                "phone_ext": "759"
            }, 
            "facility": {
                "address": {
                    "city": "Montr\u00e9al", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H4P 2S4"
                }, 
                "name": "Clinique Ovo"
            }, 
            "investigator": {
                "last_name": "Himaya Eric, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization", 
        "overall_contact": {
            "email": "k.viaud@cliniqueovo.com", 
            "last_name": "K\u00e9celle Viaud, RN", 
            "phone": "(514) 798-2000", 
            "phone_ext": "759"
        }, 
        "overall_contact_backup": {
            "email": "s.leblanc@cliniqueovo.com", 
            "last_name": "Sophie Leblanc, RN", 
            "phone": "514-798-2000", 
            "phone_ext": "617"
        }, 
        "overall_official": {
            "affiliation": "clinique ovo and CHUM", 
            "last_name": "Eric Himaya, Dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determine if the intramuscular administration of 1mg of Glucagon 10 minutes before the embryo transfer is associated with a uterine muscle relaxation.", 
            "measure": "Uterine muscle relaxation", 
            "safety_issue": "No", 
            "time_frame": "30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01674283"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Determine if the intramuscular administration of 1mg of Glucagon 10 minutes before the embryo transfer is associated with higher implantation and pregnancy rates than during embryo transfer without glucagon.", 
            "measure": "Embryo implantation and pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "7 weeks"
        }, 
        "source": "OVO R & D", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "OVO R & D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}